Haleon (HLN) Gross Profit (2021 - 2025)

Haleon's (HLN) quarterly Gross Profit came in at $4.7 billion in Q4 2025, down 27.76% on a QoQ basis from $6.5 billion in Q4 2023.

Haleon (HLN) Gross Profit (2021 - 2025) Analysis & Trends

Haleon (HLN) has 4 years of Gross Profit data on file, last reported at $4.7 billion in Q4 2025.

Quarterly Gross Profit changed N/A year-over-year to $4.7 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $15.6 billion (changed N/A YoY) and the FY2025 annual result came in at $9.4 billion, up 7.96% from the prior year.
Gross Profit slipped to $4.7 billion in Q4 2025, from $6.5 billion in the prior quarter.
In the past five years, Gross Profit ranged from a high of $6.5 billion in Q4 2023 to a low of $2.1 billion in Q2 2023.
A 4-year average of $4.5 billion and a median of $4.7 billion in 2025 frame the typical range for Gross Profit.
Annual changes were most pronounced in 2022 — Gross Profit advanced 0.13% — and 2023, when it advanced 10.78%.
Tracing HLN's Gross Profit over 4 years: stood at $5.9 billion in 2021, then gained by 0.13% to $5.9 billion in 2022, then climbed by 10.78% to $6.5 billion in 2023, then slipped by 27.76% to $4.7 billion in 2025.
The last three Gross Profit figures came in at $4.7 billion (Q4 2025), $6.5 billion (Q4 2023), and $2.1 billion (Q2 2023), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	43.76 Bn	42.80 Bn	-
2	Teva Pharmaceutical Industries	43.05 Bn	39.39 Bn	2.15 Bn
3	Zoetis	31.51 Bn	29.84 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.70 Bn	22.90 Bn	5.10 Bn
5	United Therapeutics	22.27 Bn	19.61 Bn	683.80 Mn
6	Viatris	18.83 Bn	17.95 Bn	1.46 Bn
7	Neurocrine Biosciences	15.65 Bn	15.26 Bn	935.80 Mn
8	Elanco Animal Health	12.06 Bn	11.53 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.12 Bn	9.95 Bn	-
10	Alkermes	8.27 Bn	7.61 Bn	397.90 Mn

Download Data